Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

ImmuCell Corporation

ICCC
Current price
4.46 USD +0.0099 USD (+0.22%)
Last closed 4.55 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 34 723 852 USD
Yield for 12 month -33.93 %
Week
Month
Year
ICCC
21.11.2021 - 28.11.2021

ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, including a whey protein concentrate for the nutritional and feed supplement markets. In addition, it is involved in developing Re-Tain, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine. Address: 56 Evergreen Drive, Portland, ME, United States, 04103

Analytics

WallStreet Target Price

14 USD

P/E ratio

Dividend Yield

1.19 %

Current Year

+18 568 000 USD

Last Year

+19 243 000 USD

Current Quarter

+5 396 500 USD

Last Quarter

+3 532 681 USD

Current Year

+7 649 000 USD

Last Year

+8 656 000 USD

Current Quarter

+1 266 881 USD

Last Quarter

+1 043 888 USD

Key Figures ICCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 731 963 USD
Operating Margin TTM -21.94 %
PE Ratio
Return On Assets TTM -8.77 %
PEG Ratio
Return On Equity TTM -21.74 %
Wall Street Target Price 14 USD
Revenue TTM 16 286 588 USD
Book Value 3.36 USD
Revenue Per Share TTM 2.1 USD
Dividend Share
Quarterly Revenue Growth YOY 12.5 %
Dividend Yield 1.19 %
Gross Profit TTM 7 648 779 000 USD
Earnings Share -0.81 USD
Diluted Eps TTM -0.81 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -63.4 %
Profit Margin -38.7 %

Dividend Analytics ICCC

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ICCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield 1.19 %
Last Split Factor 1:100
Payout Ratio
Last Split Date 25.07.1990
Dividend Date

Stock Valuation ICCC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 3.0342
Price Sales TTM 2.1321
Enterprise Value EBITDA -15.2095
Price Book MRQ 1.3348

Financials ICCC

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ICCC

For 52 weeks

4.26 USD 7.84 USD
50 Day MA 5.03 USD
Shares Short Prior Month 13 625
200 Day MA 5.16 USD
Short Ratio 0.45
Shares Short 6 470
Short Percent 0.1 %